Emerge Holdco

Emerge Holdco, LLC is a healthcare services holding company that owns and operates Evolution Research Group (ERG) and Lotus Clinical Research. The company provides comprehensive clinical trial services, including site management and full-service contract research organization (CRO) capabilities, with a specialized focus on neuroscience, central nervous system (CNS) disorders, and complex clinical populations. Through its subsidiaries, Emerge Holdco manages a network of over 20 wholly owned clinical research sites across the United States and offers expertise in Phase 1-4 clinical development. The organization serves biopharmaceutical clients by executing trials in therapeutic areas such as psychiatry, neurology, acute and chronic pain, sleep disorders, and metabolic diseases. Additionally, the company engages in collaborative research, such as retrospective studies examining the cognitive effects of GLP-1 agonists.